City National Bank’s Aerie Pharmaceuticals AERI Stock Holding History

City National Bank’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-82,259	Closed	-$1.45M	–	893
2015 Q2	$1.45M	Sell	82,259 -202,750	-71%	-$3.72M	0.01%	426
2015 Q1	$8.93M	Buy	285,009 +69,440	+32%	+$2.01M	0.08%	224
2014 Q4	$6.29M	Buy	215,569 +19,063	+10%	+$483K	0.05%	255
2014 Q3	$4.07M	Buy	196,506 +10,166	+5%	+$200K	0.04%	282
2014 Q2	$4.62M	Buy	186,340 +101,495	+120%	+$1.76M	0.04%	272
2014 Q1	$1.8M	Buy	+84,845	New	+$1.71M	0.03%	316

Other funds holding AERI

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

City National Bank's AERI Position: Q3 2015 in Review

City National Bank sold out of Aerie Pharmaceuticals (AERI) in Q3 2015, closing a stake of 82,259 shares — an estimated $1.45M sold.

City National Bank first reported a position in AERI in Q1 2014 and held it in 6 quarters. The position peaked at $8.93M in Q1 2015. 115 funds tracked by Wall St. Rank hold AERI as of Q3 2015.

City National Bank reported no remaining Aerie Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
City National Bank sold 82,259 Aerie Pharmaceuticals shares in Q3 2015, an estimated $1.45M.
City National Bank first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 6 quarters.
City National Bank's Aerie Pharmaceuticals position peaked at $8.93M in Q1 2015.
115 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.